Cover Image

ADVERSE DRUG REACTION MONITORING OF ATORVASTATIN IN A TERTIARY CARE HOSPITAL.

RAJESH KUMAR G

Abstract


OBJECTIVE To study the incidence and pattern of adverse effects of Atorvastatin. To assess the severity of  adverse effects of Atorvastatin. METHODOLOGY This study included 100 patients with hyperlipidemia who were taking only Atorvastatin drug. Patients who were willing to participate in the study were given a questionnaire containing  demographic data and adverse drug profile of Atorvastatin. The adverse drug reaction was documented. The causality   assessment was done by WHO assessment scale and   severity assessment by using modified Hartwig seigel severity assessment scale. RESULTS In Our study, most of the  patients belong to 41-50 years age group. Among the 100   patients who were on Atorvastatin, 73 developed adverse drug reaction. Percentage of ADRs reported was more in patients with increased doses (more than 10mg) of atorvastatin. The most common adverse drug effects documented in our study was CNS disturbances(40) followed by GI disturbances(33), myopathy(23) and increased serum   transaminases(4). Most of the ADRs come under possible category using causality assessment scale. Severity assessment showed most of the ADRs come under moderate category. CONCLUSION Most of the patients who were   taking Atorvastatin had atleast one adverse drug reaction. The ADRs mostly belong to possible category and were moderate in severity. Early identification of these adverse             effects and proper dose adjustment will make the treatment safe and more effective.

 


Full Text:

PDF

References


Dipiro J et al. Pharmacotherapy: A Pathophysiologic Approach. 6th ed, McGraw Hill 2005; 23: p385.

Goodman and Gilmans. The Pharmacological Basis of Therapeutics, 12th ed, McGraw Hill. 2011; 34:890-896.

Lippincotts illustrated reviews: Biochemistry, 5th editon, Wolters Kluver. 2011; 220-223

Geneva: World Health organization; 1975. WHO. Requirements for adverse drug reaction reporting; pp. 1039–109.

Crane FL. Biochemical functions of coenzyme Q10. J Am Coll Nutr. 2001;20:591-598.

Hsu I, Spinler SA, Johnson NE. Comparative evaluation of the safety and efficacy of HMG-CoA reductase inhibitor monotherapy in the treatment of primary hypercholesterolemia. Ann Pharmacotherapy 1995; 29:743–759.

Peter JH Smak Gregoor. Atorvastatin may cause nightmares. The BMJ 2006;332:950

Leslie et al. Statin associated memory loss: analysis of case reports. Pharmacotherapy 2003; 23(7): 871-880

Huabing Zhang, MD et al. Discontinuation of statins in routine care settings. Ann Intern Med. 2013 April 2; 158(7): 526–534.

Uppsala monitoring centre (2006), the use of WHO-UMC system for standard case causality assessment. Accessed from http://who-umc.org/graphics/4409.pdf.

Hartwig SC, Siegel J, Schneider PJ. Preventability and severity assessment in reporting adverse drug reaction. Am J Hosp Pharm 1992;49:2229-32

Robert K Murray et al. Harper's Illustrated Biochemistry. 28th ed. McGraw Hill. 2009; 464-466

Ihab I El-Hajj. Atorvastatin induced severe gastric ulceration: A case report. World J Gastroenterol 2005 May 28; 11(20): 3159-3160.

Graham DJ et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid-lowering drugs. JAMA 2004; 292(21):2585-90.

David E. Cohen et al. An Assessment of Statin Safety by Hepatologists. Am J Cardiol 2006;97:77C–81C

Caso G et al. Effect of coenzyme q10 on myopathic symptoms in patients treated with statins. Am J Cardiol 2007 May 15; 99(10):1409-12.

Pravst, Igor; Zmitek, Katja; Zmitek, Janko (2010). "Coenzyme Q10 Contents in Foods and Fortification Strategies". Critical Reviews in Food Science and Nutrition 50 (4): 269–80

Zlatohlavek L, Vrablik M, Grauova B, Motykova E, Ceska R. The effect of coenzyme Q10 in statin myopathy. Neuro Endocrinol Lett. 2012;33 Suppl 2:98-101


Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

An Initiative of The Tamil Nadu Dr M.G.R. Medical University